Hospital acquired bacterial infections (HABI) or nosocomial infections are type of infections commonly caused by bacterial pathogens and are acquired in healthcare facilities or hospitals. These pathogens should be examined in all patients who have developed some kind of clinical deterioration unexplained during the initial diagnosis. Currently, HABI market is a lucrative market venture due to increasing incidence rate of hospital acquired infections, which makes this industry a highly profitable and attractive market.
Read Report Overview: https://www.transparencymarketresearch.com/hospital-acquired-bacterial-infections.html
- DNA Sequencing
- Colorimetric Methods
- Microarrays
- RT-PCR
- Solid-phase Hybridization Techniques
- Phage-based Assays
- The Nitrate Reductase Assay
- Phenotypic Methods
DownloadBrochureCopy of this Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2910
- Urinary Tract Infections (UTI)
- Pneumonia
- Blood Stream Infections (BSI)
- Surgical Site Infections
- Aminoglycosides
- B-Lactam Antibiotics
- Lincosamides
- Glycopeptides
- Carbapenems
- Macrolides
- Lipopeptides
- Polypeptides
- Quinolones
- Penicillins
- Sulfonamides
- Tetracyclines
In the geographical analysis, North America is the leading market for hospital acquired bacterial infections treatment and testing market. Due to stringent hospital regulatory policies and increased government initiatives to prevent and control various hospital-acquired infections, this region is able to maintain its dominant position across the world. Europe closely follows North America is terms of growth, due to increasing incidence of hospital-acquired infections. According to the Health Protection Agency (HPA) approximately of patients in hospitals in England acquire some form of bacterial infection during their hospital stay. However, other regions such as South East Asia, Middle East and Latin America are expected to be the promising markets in the near future. Owing to the rising disposable income among population, increasing incidence of bacterial infections and developing healthcare infrastructure, these regions are expected to be the potential market in the near future.